BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6617895)

  • 1. Impaired renal function and aluminum metabolism.
    Mayor GH; Burnatowska-Hledin MA
    Fed Proc; 1983 Oct; 42(13):2979-83. PubMed ID: 6617895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum, parathyroid hormone, and osteomalacia.
    Burnatowska-Hledin MA; Kaiser L; Mayor GH
    Spec Top Endocrinol Metab; 1983; 5():201-26. PubMed ID: 6422572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoaciduria--its relationship to vitamin D and parathyroid hormone.
    Phillips ME
    Crit Rev Clin Lab Sci; 1980; 12(3):215-39. PubMed ID: 6998653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum administration in the rat separately affects the osteoblast and bone mineralization.
    Rodriguez M; Felsenfeld AJ; Llach F
    J Bone Miner Res; 1990 Jan; 5(1):59-67. PubMed ID: 2309580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats.
    Lieuallen WG; Weisbrode SE
    J Bone Miner Res; 1991 Jul; 6(7):751-7. PubMed ID: 1950679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.
    Wills MR; Savory J
    Crit Rev Clin Lab Sci; 1989; 27(1):59-107. PubMed ID: 2647415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotaemic rat.
    Felsenfeld AJ; Machado L; Bover J; Trinidad P; Rodriguez M
    Nephrol Dial Transplant; 1993; 8(4):325-34. PubMed ID: 8390007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of renal calbindin-D28K.
    Hemmingsen C
    Pharmacol Toxicol; 2000; 87 Suppl 3():5-30. PubMed ID: 11097107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic accumulation of aluminum on renal function, cortical renal oxidative stress and cortical renal organic anion transport in rats.
    Mahieu ST; Gionotti M; Millen N; Elías MM
    Arch Toxicol; 2003 Nov; 77(11):605-12. PubMed ID: 12928767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of aluminum loading on the renal response to parathyroid hormone in the vitamin D-replete rat.
    Klein GL; Lee TC; Bishop JE; Vaccaro ML; Jongen M; Kurokawa K; Coburn JW; Norman AW
    Biochem Med Metab Biol; 1986 Dec; 36(3):363-8. PubMed ID: 3026424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term aluminum administration in the rat: reductions in bone formation without osteomalacia.
    Goodman WG
    J Lab Clin Med; 1984 May; 103(5):749-57. PubMed ID: 6715954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated accumulation of aluminum by osteoid matrix in vitamin D deficiency. An animal model of aluminum toxicity.
    Hodsman AB; Anderson C; Leung FY
    Miner Electrolyte Metab; 1984; 10(5):309-15. PubMed ID: 6493159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
    Alfrey AC; LeGendre GR; Kaehny WD
    N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental aluminum-induced bone disease: studies in vivo.
    Goodman WG
    Kidney Int Suppl; 1986 Feb; 18():S32-6. PubMed ID: 3517461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of parathyroid function and parathyroidectomy in the outcome of aluminium-related dialysis encephalopathy.
    Campistrus de Gencarelli N; Cournot-Witmer G; Zingraff J; Drüeke T
    Nephrol Dial Transplant; 1986; 1(3):192-8. PubMed ID: 3110673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent and progressing accumulation of aluminum in bone without definite histological osteomalacic aspects in chronic hemodialysis patients.
    Suzuki M; Hirasawa Y; Tanizawa T
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S51-5. PubMed ID: 8608664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum in tissues.
    Van de Vyver FL; De Broe ME
    Clin Nephrol; 1985; 24 Suppl 1():S37-57. PubMed ID: 3915959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
    Ito H; Kinugasa E
    Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.